Company News & Press Releases

Jun 29, 2026 | Company News, Long Covid

New Frontiers article: examining chronic exposure to SARS-CoV-2

A scientist in a white lab coat using a microscope in a laboratory, representing Attomarker's medical research and diagnostic testing.
Feb 26, 2026 | Company News

Crowdfunding the Long Covid Journey

Attomarker is developing advanced diagnostics for immunology unmet need
Feb 17, 2026 | Press Releases

EpitogenX and Attomarker Sign Strategic Co-Development Agreement

Feb 6, 2026 | Investment News, Press Releases

Attomarker launches Acceleration Round

May 29, 2024 | Company News

Attomarker has been selected as one of the companies by Innovate UK

Jun 29, 2026 | Company News, Long Covid

New Frontiers article: examining chronic exposure to SARS-CoV-2

A scientist in a white lab coat using a microscope in a laboratory, representing Attomarker's medical research and diagnostic testing.
Feb 26, 2026 | Company News

Crowdfunding the Long Covid Journey

May 29, 2024 | Company News

Attomarker has been selected as one of the companies by Innovate UK

Attomarker is developing advanced diagnostics for immunology unmet need
Feb 17, 2026 | Press Releases

EpitogenX and Attomarker Sign Strategic Co-Development Agreement

Feb 6, 2026 | Investment News, Press Releases

Attomarker launches Acceleration Round